A team of researchers from the University of California, Berkeley, and the University of Tokyo have developed a new delivery system for CRISPR gene editing technology using lipid nanoparticles. The technology allows for more efficient and targeted delivery of CRISPR components to specific cells in the body.
CRISPR technology has the potential to revolutionize medicine by allowing researchers to edit the genetic code of cells, potentially curing genetic diseases. However, one of the major challenges of CRISPR is delivering the necessary components, including the Cas9 enzyme and the guide RNA, to the target cells without causing adverse effects.
The researchers developed a lipid nanoparticle delivery system that can efficiently encapsulate and protect the CRISPR components, while also allowing for targeted delivery to specific cells. The system is based on a new type of lipid nanoparticle called a charged multilamellar vesicle (cMLV), which is made up of multiple layers of lipids with a positive charge on the outer layer.
Continue reading… “New lipid nanoparticle CRISPR delivery system developed”
